27.27
2.19%
-0.61
Royalty Pharma plc (RPRX) 最新ニュース
Panagora Asset Management Inc. Buys 215,142 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
MarketBeat
Shareholders in Royalty Pharma (NASDAQ:RPRX) are in the red if they invested a year ago - Yahoo Sport Australia
Yahoo Sport Australia
Charles Schwab Investment Management Inc. Grows Holdings in Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Defense World
Amalgamated Bank Sells 3688 Shares of Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Defense World
National Bank of Canada FI Has $986,000 Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by National Bank of Canada FI - Defense World
Defense World
Teacher Retirement System of Texas Reduces Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Defense World
Victory Capital Management Inc. Reduces Holdings in Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Defense World
Victory Capital Management Inc. Has $7.46 Million Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
MarketBeat
M&T Bank Corp Grows Position in Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Defense World
Torray Investment Partners LLC Increases Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
MarketBeat
(RPRX) Investment Report - Stock Traders Daily
Stock Traders Daily
Royalty Pharma to Present at Upcoming Investor Conferences
GlobeNewswire Inc.
Van ECK Associates Corp Buys 2944 Shares of Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Defense World
Royalty Pharma plc (NASDAQ:RPRX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year - Simply Wall St
Simply Wall St
Here's What Analysts Are Forecasting For Royalty Pharma plc (NASDAQ:RPRX) After Its First-Quarter Results - Yahoo Finance UK
Yahoo Finance UK
Metis Global Partners LLC Invests $375000 in Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Defense World
Royalty Pharma (NASDAQ:RPRX) Stock Rating Lowered by StockNews.com - Defense World
Defense World
Only Four Days Left To Cash In On Royalty Pharma's (NASDAQ:RPRX) Dividend - Yahoo Finance UK
Yahoo Finance UK
Royalty Pharma (NASDAQ:RPRX) Stock Rating Lowered by StockNews.com - MarketBeat
MarketBeat
Royalty Pharma Stock: Solid Start Of The Year, Buy Confirmed (NASDAQ:RPRX) - Seeking Alpha
Seeking Alpha
Royalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Royalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Royalty Pharma PLC (RPRX): A Strategic SWOT Insight - Yahoo Finance
Yahoo Finance
Earnings call: Royalty Pharma reports robust growth and strategic acquisitions - Investing.com Australia
Investing.com Australia
Earnings call: Royalty Pharma reports robust growth and strategic acquisitions - Investing.com
Investing.com
Earnings call: Royalty Pharma reports robust growth and strategic acquisitions - Investing.com India
Investing.com India
Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab - citybiz
citybiz
Royalty Pharma (RPRX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Zacks Investment Research
Zacks Investment Research
Royalty Pharma (RPRX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Yahoo Finance
Royalty Pharma (RPRX) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance
Yahoo Finance
Royalty Pharma (RPRX) Beats Q1 Earnings and Revenue Estimates - Zacks Investment Research
Zacks Investment Research
Royalty Pharma Reports First Quarter 2024 Results - 09.05.2024 - wallstreet:online
wallstreet:online
Royalty Pharma plc (RPRX) to Acquire Royalty Interest in Sanofi's (SNY) Frexalimab - StreetInsider.com
StreetInsider.com
Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
GlobeNewswire Inc.
The Best Healthcare Stocks to Buy - Morningstar
Morningstar
Crescent Capital BDC (CCAP) Q1 Earnings and Revenues Surpass Estimates
Zacks Investment Research
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Swiss National Bank - MarketBeat
MarketBeat
Why Earnings Season Could Be Great for Royalty Pharma (RPRX) - Zacks Investment Research
Zacks Investment Research
RPRX Breaks Above 3% Yield Territory - Nasdaq
Nasdaq
Why Earnings Season Could Be Great for Royalty Pharma (RPRX)
Zacks Investment Research
RPRX Breaks Above 3% Yield Territory - Nasdaq
Nasdaq
Russell Investments Group Ltd. Purchases 54,907 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
MarketBeat
Royalty Pharma (RPRX) Scheduled to Post Quarterly Earnings on Thursday - Defense World
Defense World
Royalty Pharma plc (NASDAQ:RPRX) Receives $46.75 Consensus Target Price from Analysts - MarketBeat
MarketBeat
Royalty Pharma (RPRX) Scheduled to Post Quarterly Earnings on Thursday - Defense World
Defense World
Insights Into Royalty Pharma (RPRX) Q1: Wall Street Projections for Key Metrics
Zacks Investment Research
Insights Into Royalty Pharma (RPRX) Q1: Wall Street Projections for Key Metrics - Nasdaq
Nasdaq
Insights Into Royalty Pharma (RPRX) Q1: Wall Street Projections for Key Metrics - Zacks Investment Research
Zacks Investment Research
Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by First Trust Direct Indexing L.P. - Defense World
Defense World
大文字化:
|
ボリューム (24 時間):